These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29230387)

  • 1. Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib.
    Bombeccari GP; Garagiola U; Pallotti F; Rossi M; Porrini M; Giannì AB; Spadari F
    Maxillofac Plast Reconstr Surg; 2017 Dec; 39(1):37. PubMed ID: 29230387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal pigmentation of the hard palate in a patient taking imatinib.
    Lyne A; Creedon A; Bailey BM
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25883257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral pigmentation in the hard palate associated with imatinib mesylate therapy: a report of three cases.
    Mattsson U; Halbritter S; Mörner Serikoff E; Christerson L; Warfvinge G
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 May; 111(5):e12-6. PubMed ID: 21330162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blue palate-A case series of imatinib-related oral pigmentation and literature review.
    Donnell CC; Walton RL; Carrozzo M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jan; 131(1):49-61. PubMed ID: 33199217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rare Case of Melanosis of the Hard Palate Mucosa in a Patient with Chronic Myeloid Leukemia.
    Romeo U; Palaia G; Fantozzi PJ; Tenore G; Bosco D
    Case Rep Dent; 2015; 2015():817094. PubMed ID: 26451262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib-induced diffuse hyperpigmentation of the oral mucosa, the skin, and the nails in a patient affected by chronic myeloid leukemia: report of a case and review of the literature.
    Di Tullio F; Mandel VD; Scotti R; Padalino C; Pellacani G
    Int J Dermatol; 2018 Jul; 57(7):784-790. PubMed ID: 29417559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of oral mucosa hyperpigmentation with imatinib mesylate use: a cross-sectional study and a systematic literature review.
    Oliveira SR; de Azevedo Branco LG; Rocha AL; Travassos DV; Magalhães GHR; Fonseca FP; Mesquita RA; Abreu LG; da Silva TA
    Clin Oral Investig; 2019 Dec; 23(12):4371-4382. PubMed ID: 30968242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal pigmentation caused by imatinib: report of three cases.
    Li CC; Malik SM; Blaeser BF; Dehni WJ; Kabani SP; Boyle N; Toner M; Woo SB
    Head Neck Pathol; 2012 Jun; 6(2):290-5. PubMed ID: 22209988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial.
    Kantarjian HM; Hochhaus A; Saglio G; De Souza C; Flinn IW; Stenke L; Goh YT; Rosti G; Nakamae H; Gallagher NJ; Hoenekopp A; Blakesley RE; Larson RA; Hughes TP
    Lancet Oncol; 2011 Sep; 12(9):841-51. PubMed ID: 21856226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dasatinib: a review of its use in the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia.
    McCormack PL; Keam SJ
    Drugs; 2011 Sep; 71(13):1771-95. PubMed ID: 21902298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperpigmentation due to imatinib: A rare case of cutaneous involvement.
    Rehman H; Hakim N; Sugarman R; Seetharamu N; Saif MW
    J Oncol Pharm Pract; 2020 Sep; 26(6):1511-1515. PubMed ID: 32067560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib-associated hyperpigmentation of the palate in post-HSCT patient.
    Resende RG; Teixeira RG; Vasconcelos Fde O; Silva ME; Abreu MH; Gomez RS
    J Craniomaxillofac Surg; 2012 Jul; 40(5):e140-3. PubMed ID: 21862339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spotlight on imatinib mesylate in chronic myeloid leukemia.
    Curran MP; Croom KF; Goa KL
    BioDrugs; 2004; 18(3):207-10. PubMed ID: 15161340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-associated hyperpigmentation of the oral mucosa: report of four cases.
    Tosios KI; Kalogirou EM; Sklavounou A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Mar; 125(3):e54-e66. PubMed ID: 29287748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral lesions associated with imatinib mesylate therapy: five new cases and a literature review.
    Hwang YJ; Kho HS
    Int J Oral Maxillofac Surg; 2024 Oct; 53(10):873-880. PubMed ID: 38777710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoinduced dermatitis and oral lichenoid reaction in a chronic myeloid leukemia patient treated with imatinib mesylate.
    Brazzelli V; Muzio F; Manna G; Moggio E; Vassallo C; Orlandi E; Fiandrino G; Lucioni M; Borroni G
    Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):2-5. PubMed ID: 22211996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serious skin reaction associated with imatinib in a patient with chronic myeloid leukemia.
    Albayrak M; Celebi H; Albayrak A; Can ES; Aslan V; Onec B; Coban I
    Eurasian J Med; 2011 Dec; 43(3):192-5. PubMed ID: 25610192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Livedoid skin reaction probably due to imatinib therapy.
    Martínez-González MC; del Pozo J; Yebra-Pimentel MT; Pérez M; Almagro M; Fonseca E
    Ann Pharmacother; 2007 Jan; 41(1):148-52. PubMed ID: 17190842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pigmentary changes in a patient treated with imatinib.
    Balagula Y; Pulitzer MP; Maki RG; Myskowski PL
    J Drugs Dermatol; 2011 Sep; 10(9):1062-6. PubMed ID: 22052279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term mucocutaneous adverse effects of imatinib in Indian chronic myeloid leukemia patients.
    Vinay K; Yanamandra U; Dogra S; Handa S; Suri V; Kumari S; Khadwal A; Prakash G; Lad D; Varma S; Malhotra P
    Int J Dermatol; 2018 Mar; 57(3):332-338. PubMed ID: 29266186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.